News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Roche’s Avastin Fails to Help Early-Stage Colon Cancer Patients in Study
September 20, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- Roche Holding AG’s Avastin tumor medicine failed to meet the main goal of a late-stage study in early colon cancer.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase III
Roche
MORE ON THIS TOPIC
Cardiovascular disease
Novo’s Wegovy Cuts Cardio Risk by 57% Versus Tirzepatide
September 2, 2025
·
2 min read
·
Tristan Manalac
Obesity
Lilly Ends Two Mid-Stage Trials for Second Obesity Asset
September 2, 2025
·
2 min read
·
Tristan Manalac
Immunology and inflammation
J&J Ends Rheumatoid Arthritis Program After Disappointing Mid-Stage Data
August 29, 2025
·
2 min read
·
Tristan Manalac
Alzheimer’s
Prothena’s Alzheimer’s Drug Comes With Familiar Side Effect in Phase I Test
August 28, 2025
·
2 min read
·
Annalee Armstrong
